Connect with us

Government

Top Biotech Stocks To Invest In Today? 3 To Watch This Week

Should investors be keeping an eye on these movers in the biotech space?
The post Top Biotech Stocks To Invest In Today? 3 To Watch This Week appeared…

Published

on

Are These The Best Biotech Stocks To Buy Right Now?

Even with inflation data coming in hotter-than-expected, investors would likely be looking for the most active stocks today. Should this be the case, biotech stocks would make for a viable option in the stock market now. For the most part, this would be the case as the industry continues to churn out new developmental pipeline updates. The likes of which can act as catalysts for the top biotech stocks around. For one thing, companies gaining momentum from regulatory updates could draw attention as markets react to the latest inflation figures.

For those unaware, the Bureau of Labor Statistics’ Consumer Price Index (CPI) reading for May has been released this past week. According to the report, the CPI for May is up by 8.6% year-over-year. This would be above consensus economist estimates of an 8.3% increase. Not to mention, it would also be the biggest jump in this key inflationary measure since 1981. With inflation at a 40-year high, more adventurous investors could be considering the headline-making names in the biotech space now.

Take Bluebird bio (NASDAQ: BLUE) for example. Just last week, the company received a positive update on its gene therapy, eli-cel. According to Bluebird, the U.S. Food and Drug Administration’s (FDA) advisory committee unanimously endorsed the treatment for use in early active cerebral adrenoleukodystrophy. At the same time, coronavirus vaccine makers such as Moderna (NASDAQ: MRNA) are also hard at work. Earlier this week, the company revealed that its updated booster shot produces stronger responses against the Omicron variant of the virus. With all that in mind, here are three more biotech stocks to note in the stock market today.

Biotech Stocks To Buy [Or Sell] This Month

Pfizer Inc.

Pfizer is a biotech company that continues to bring life-saving therapies, medicines, and vaccines to the masses. With over 170 years of experience in the industry, it advances wellness and treatments for some of the most challenging diseases in today’s society. This includes its coronavirus vaccine with over 2 billion doses shipped across the globe.

On Thursday, the company announced that it has completed the acquisition of ReViral. ReViral is a private clinical-stage biopharmaceutical company. It focuses on discovering and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV). Accordingly, ReViral brings to Pfizer a portfolio of promising therapeutic candidates, including sisunatovir, an orally administered inhibitor designed to block fusion of the RSV virus to the host cell. Sisunatovir has fast-track designation by the U.S. FDA. It has significantly reduced viral load in a phase 2 RSV human challenge study in healthy adults. The treatment is also currently in phase 2 clinical development in infants.

Also, Pfizer recently announced that it plans to invest $120 million to produce its Paxlovid oral treatment for the coronavirus. In brief, the investment will expand on the production of active pharmaceutical ingredients (API) and registered starting materials. These are used in the manufacturing of nirmatrelvir, which makes up one component of Paxlovid. The investment will help expand the facility at Kalamazoo, Michigan. Given all of this, is PFE stock worth investing in right now?

PFE stock chart
Source: TD Ameritrade TOS

[Read More] Most Active Stocks To Buy Today? 4 Metaverse Stocks To Watch

AbbVie Inc.

Following that, we have AbbVie, a health care company that discovers and develops innovative medicines that help solve serious health issues that plague the world today. It has an impressive portfolio of therapeutics across several key fields like oncology and immunology. The company has been firing on all cylinders lately with multiple announcements of positive findings in the last few months.

Notably, this would include positive results from its Phase 3 SELECT-AXIS 2 Trials of Upadacitinib. Diving in, it demonstrated significantly greater improvements in signs and symptoms, pain, function, and health-related quality of life when compared to a placebo at week 14. Furthermore, safety data were consistent with the known safety profile of upadacitinib, with no new risks observed. “The new data observed from SELECT-AXIS 2 reinforce the potential of upadacitinib for patients across the spectrum of axial spondyloarthritis disease,” said Neil Gallagher, M.D., Ph.D., vice president, development, chief medical officer, AbbVie. “At AbbVie, the needs of patients drive us to continue to innovate new ways to change the treatment landscape. We are encouraged by these positive data, which we hope will lead to the availability of a new treatment option for patients with nr-axSpA.”

Last week, it also announced new data from Cohort 3 of its Phase 2 REFINE study of investigational navitoclax. Navitoclax is used for patients with myelofibrosis (MF), a rare and difficult to treat blood cancer. The data is supportive of early intervention in MF to achieve improved clinical outcomes in spleen volume reduction, symptoms score, and bone marrow fibrosis. With all this in mind, is ABBV stock a buy in your opinion?

ABBV stock chart
Source: TD Ameritrade TOS

[Read More] Best Food Stocks To Watch In June 2022

Novavax Inc.

Another notable player in the biotech space now would be Novavax. Overall, the biotech company specializes in developing vaccines to treat infectious diseases. As it stands, the company’s portfolio consists of vaccines for Ebola, influenza, and respiratory syncytial virus among other emerging infectious illnesses. Also worth noting, the company is actively working on a coronavirus vaccine. Thanks to the latest developments on this front, NVAX stock could be worth looking out for.

In detail, Novavax received the green light from the FDA’s advisory panel regarding the use of its coronavirus vaccine in adults. Following a 21 to 0 vote, the FDA is now recommending the company’s shot for Emergency Use Authorization (EUA). This would make Novavax the fourth company to receive this regulatory feat. Moreover, it is also the first protein-based coronavirus vaccine available in the U.S.

All in all, CEO Stanley Erck notes that the advisory panel’s positive comments showcase the strength in Novavax’s clinical data. On top of that, the also argues that it highlights the importance of protein-based coronavirus vaccine development. With this being a more conventional means of vaccine development, health officials could be appealing to the unvaccinated population now. After taking all this into consideration, will you be adding NVAX stock to your portfolio anytime soon?

NVAX stock chart
Source: TD Ameritrade TOS

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

The post Top Biotech Stocks To Invest In Today? 3 To Watch This Week appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

on

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Government

Walmart joins Costco in sharing key pricing news

The massive retailers have both shared information that some retailers keep very close to the vest.

Published

on

As we head toward a presidential election, the presumed candidates for both parties will look for issues that rally undecided voters. 

The economy will be a key issue, with Democrats pointing to job creation and lowering prices while Republicans will cite the layoffs at Big Tech companies, high housing prices, and of course, sticky inflation.

The covid pandemic created a perfect storm for inflation and higher prices. It became harder to get many items because people getting sick slowed down, or even stopped, production at some factories.

Related: Popular mall retailer shuts down abruptly after bankruptcy filing

It was also a period where demand increased while shipping, trucking and delivery systems were all strained or thrown out of whack. The combination led to product shortages and higher prices.

You might have gone to the grocery store and not been able to buy your favorite paper towel brand or find toilet paper at all. That happened partly because of the supply chain and partly due to increased demand, but at the end of the day, it led to higher prices, which some consumers blamed on President Joe Biden's administration.

Biden, of course, was blamed for the price increases, but as inflation has dropped and grocery prices have fallen, few companies have been up front about it. That's probably not a political choice in most cases. Instead, some companies have chosen to lower prices more slowly than they raised them.

However, two major retailers, Walmart (WMT) and Costco, have been very honest about inflation. Walmart Chief Executive Doug McMillon's most recent comments validate what Biden's administration has been saying about the state of the economy. And they contrast with the economic picture being painted by Republicans who support their presumptive nominee, Donald Trump.

Walmart has seen inflation drop in many key areas.

Image source: Joe Raedle/Getty Images

Walmart sees lower prices

McMillon does not talk about lower prices to make a political statement. He's communicating with customers and potential customers through the analysts who cover the company's quarterly-earnings calls.

During Walmart's fiscal-fourth-quarter-earnings call, McMillon was clear that prices are going down.

"I'm excited about the omnichannel net promoter score trends the team is driving. Across countries, we continue to see a customer that's resilient but looking for value. As always, we're working hard to deliver that for them, including through our rollbacks on food pricing in Walmart U.S. Those were up significantly in Q4 versus last year, following a big increase in Q3," he said.

He was specific about where the chain has seen prices go down.

"Our general merchandise prices are lower than a year ago and even two years ago in some categories, which means our customers are finding value in areas like apparel and hard lines," he said. "In food, prices are lower than a year ago in places like eggs, apples, and deli snacks, but higher in other places like asparagus and blackberries."

McMillon said that in other areas prices were still up but have been falling.

"Dry grocery and consumables categories like paper goods and cleaning supplies are up mid-single digits versus last year and high teens versus two years ago. Private-brand penetration is up in many of the countries where we operate, including the United States," he said.

Costco sees almost no inflation impact

McMillon avoided the word inflation in his comments. Costco  (COST)  Chief Financial Officer Richard Galanti, who steps down on March 15, has been very transparent on the topic.

The CFO commented on inflation during his company's fiscal-first-quarter-earnings call.

"Most recently, in the last fourth-quarter discussion, we had estimated that year-over-year inflation was in the 1% to 2% range. Our estimate for the quarter just ended, that inflation was in the 0% to 1% range," he said.

Galanti made clear that inflation (and even deflation) varied by category.

"A bigger deflation in some big and bulky items like furniture sets due to lower freight costs year over year, as well as on things like domestics, bulky lower-priced items, again, where the freight cost is significant. Some deflationary items were as much as 20% to 30% and, again, mostly freight-related," he added.

Read More

Continue Reading

Government

Walmart has really good news for shoppers (and Joe Biden)

The giant retailer joins Costco in making a statement that has political overtones, even if that’s not the intent.

Published

on

As we head toward a presidential election, the presumed candidates for both parties will look for issues that rally undecided voters. 

The economy will be a key issue, with Democrats pointing to job creation and lowering prices while Republicans will cite the layoffs at Big Tech companies, high housing prices, and of course, sticky inflation.

The covid pandemic created a perfect storm for inflation and higher prices. It became harder to get many items because people getting sick slowed down, or even stopped, production at some factories.

Related: Popular mall retailer shuts down abruptly after bankruptcy filing

It was also a period where demand increased while shipping, trucking and delivery systems were all strained or thrown out of whack. The combination led to product shortages and higher prices.

You might have gone to the grocery store and not been able to buy your favorite paper towel brand or find toilet paper at all. That happened partly because of the supply chain and partly due to increased demand, but at the end of the day, it led to higher prices, which some consumers blamed on President Joe Biden's administration.

Biden, of course, was blamed for the price increases, but as inflation has dropped and grocery prices have fallen, few companies have been up front about it. That's probably not a political choice in most cases. Instead, some companies have chosen to lower prices more slowly than they raised them.

However, two major retailers, Walmart (WMT) and Costco, have been very honest about inflation. Walmart Chief Executive Doug McMillon's most recent comments validate what Biden's administration has been saying about the state of the economy. And they contrast with the economic picture being painted by Republicans who support their presumptive nominee, Donald Trump.

Walmart has seen inflation drop in many key areas.

Image source: Joe Raedle/Getty Images

Walmart sees lower prices

McMillon does not talk about lower prices to make a political statement. He's communicating with customers and potential customers through the analysts who cover the company's quarterly-earnings calls.

During Walmart's fiscal-fourth-quarter-earnings call, McMillon was clear that prices are going down.

"I'm excited about the omnichannel net promoter score trends the team is driving. Across countries, we continue to see a customer that's resilient but looking for value. As always, we're working hard to deliver that for them, including through our rollbacks on food pricing in Walmart U.S. Those were up significantly in Q4 versus last year, following a big increase in Q3," he said.

He was specific about where the chain has seen prices go down.

"Our general merchandise prices are lower than a year ago and even two years ago in some categories, which means our customers are finding value in areas like apparel and hard lines," he said. "In food, prices are lower than a year ago in places like eggs, apples, and deli snacks, but higher in other places like asparagus and blackberries."

McMillon said that in other areas prices were still up but have been falling.

"Dry grocery and consumables categories like paper goods and cleaning supplies are up mid-single digits versus last year and high teens versus two years ago. Private-brand penetration is up in many of the countries where we operate, including the United States," he said.

Costco sees almost no inflation impact

McMillon avoided the word inflation in his comments. Costco  (COST)  Chief Financial Officer Richard Galanti, who steps down on March 15, has been very transparent on the topic.

The CFO commented on inflation during his company's fiscal-first-quarter-earnings call.

"Most recently, in the last fourth-quarter discussion, we had estimated that year-over-year inflation was in the 1% to 2% range. Our estimate for the quarter just ended, that inflation was in the 0% to 1% range," he said.

Galanti made clear that inflation (and even deflation) varied by category.

"A bigger deflation in some big and bulky items like furniture sets due to lower freight costs year over year, as well as on things like domestics, bulky lower-priced items, again, where the freight cost is significant. Some deflationary items were as much as 20% to 30% and, again, mostly freight-related," he added.

Read More

Continue Reading

Trending